Validation of a Flow Cytometric Assay to Detect Antibodies to a Novel Cell Therapy for Immunogenicity Assessment

  • PDF (590.38 KB)

To assess the toxicokinetics (TK) of CBX129801 in Sprague Dawley
Rats following once weekly subcutaneous injection for 26 doses.

Read More

Proof-of-Concept of a Qualitative qPCR Assay for RCL Monitoring

  • PDF (297.70 KB)

qPCR assays for RCL monitoring are a rapid method to detect and usually quantify lentiviral genes, such as the envelope gene vesicular stomatitis virus G…

Read More

In-Cell ELISA Assays to Assess Drug Relative Potency Using the Cytation Imaging Reader for Sample Analysis

  • PDF (423.07 KB)

Potency assays are crucial characterization tools for almost all biotherapeutics during clinical and pre-clinical development for quality control and market authorization purposes.

Read More

Points to Consider in the Development of Activity and Potency Assays for Enzyme Biotherapeutics

  • PDF (512.88 KB)

The ability of enzymes to remain active outside their source organism makes them an ideal candidate for biotherapeutics.

Read More

Qualification of a Neurology 2-Plex B (Nf-L, GFAP) Quanterix Simoa® Assay Using a Novel Approach

  • PDF (317.12 KB)

Biomarkers associated with neurodegenerative diseases and traumatic brain injuries, including Nf-L (Neurofilament light) and GFAP (Glial fibrillary acidic protein) have been identified as potential prognostic…

Read More

Potency Assay Development for Gene Therapy Products – Approaches and Points to Consider in Data Processing

  • PDF (757.98 KB)

Gene therapies – including AAVs, engineered viruses and polymer formulated oligonucleotides/plasmids – are among the highest growth area in biopharmaceuticals.

Read More

Toxicokinetics of Pirfenidone in Dogs Following Inhalation in a Nebulized Aerosol Formulation

  • PDF (25.99 MB)

To assess the toxicokinetics (TK) exposure of pirfenidone (AP01) during a 28-day oronasal dog inhalation toxicity study

Read More

Comparison of the Pharmacokinetics of Four Different Dose- Frequency Combinations of AMZ001 (Diclofenac Gel 3.06%) with Voltaren® (Diclofenac Gel 1%) in Healthy Subjects in a Phase 1 Study

  • PDF (25.61 MB)

To evaluate how the steady state levels of AMZ001 applied one or two times daily compare to Voltaren® applied four times daily in healthy subjects.

Read More

Efficient and Economical Preclinical Pharmacokinetic Analyses for Human Therapeutic Antibodies and Constructs, Using a Validated Human Immunoglobulin Immunoassay in Plasma of Mice, Rats, and Monkeys

  • PDF (27.83 MB)

This work was conducted to develop and validate (fit-for-purpose, FFP) an efficient means for pharmacokinetic (PK) analyses of large molecule drugs composed in part, or…

Read More